Blog: Nestle receives green light on Pfizer deal

Michelle Russell | 6 November 2012

Swiss food group Nestle today (6 November) received approval from the Chinese Ministry of Commerce for its US$11.85bn deal to acquire Pfizer's infant nutrition business.

The approval brings Nestle another step closer to completing the acquisition, which was announced in April this year, enabling the world's largest infant nutrition group to extend its lead in this fast-growing category.

Pfizer Nutrition operates in more than 60 countries globally and 85% of sales are generated in emerging markets, meaning the acquisition effectively fills in the blanks on the map for Nestle. It will provide the company with increased scale in a high-growth, high-margin, category in fast-growing developing markets, CEO Paul Bulcke told investors as it emerged as victor of competitive auction process.

Nestle beat companies including Danone and Mead Johnson to seal the agreement. The next hurdle, however, is to receive approval from anti-trust bodies in several countries in order to fully complete the acquisition.


BLOG

Food company interest in M&A to continue to climb - EY

There has been an increase in M&A among companies in the food sector in recent months - and management consultants at EY expect to the trend to continue....

BLOG

Could proxy fight hit PepsiCo?

Nelson Peltz is not letting go. The US billionaire investor is continuing in his quest to get PepsiCo to split in two - and has reportedly suggested a proxy battle with the company could be on the hor...

BLOG

Bitesize: just-food's new SME interview section

just-food has launched a section on its website dedicated to interviewing internationally-ambitious small- and medium-sized enterprises. ...

BLOG

China's Yili breaks new ground for emerging market dairies

The boom in demand for dairy products in emerging markets has been underlined by the latest data on the largest companies in the industry....

just-food homepage



Forgot your password?